InsidersTradesSigma
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Constantino Michael T., Directeur. Officer active across 2 companies, notably 9 METERS BIOPHARMA, INC.. In total, 7 disclosures have been recorded. Total volume traded: €72k. The latest transaction was disclosed on 23 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
€7,12216,000 shares@ €0.445112.1% of flow
Common Stock
SEC:0001578563-22-000018:0·
Ideal exit: 17 Feb 2023 (T+270)
€9,0432,000 shares@ €4.521670.2% of flow
Common Stock
SEC:0001818382-22-000047:0·
Ideal exit: 17 Feb 2023 (T+270)
€16,84526,508.74 shares@ €0.635428.6% of flow
Common stock
SEC:0001551986-22-000025:0·
Ideal exit: 17 May 2021 (T+270)
€1,921200 shares@ €9.6047100.0% of flow
Common Stock
SEC:0001104659-21-143251·
Ideal exit: 19 Aug 2022 (T+270)
€1,921200 shares@ €9.604714.9% of flow
Common Stock
SEC:0001104659-21-143251:0·
Ideal exit: 19 Aug 2022 (T+270)
€17,45918,000 shares@ €0.97100.0% of flow
Common stock
SEC:0001551986-21-000099·
Ideal exit: 21 May 2022 (T+270)
€17,45918,000 shares@ €0.9729.6% of flow
Common stock
SEC:0001551986-21-000099:0·
Ideal exit: 21 May 2022 (T+270)
7 of 7 declarations
About Constantino Michael T.
Michael T. Constantino serves as a Board Member at 9 METERS BIOPHARMA, INC. and Humacyte, Inc. He contributes to the governance and strategy of both companies, bringing his expertise in the biopharmaceutical sector. With significant experience, he plays a key role in guiding strategic decisions and optimizing performance. His commitment to innovation and sustainability is essential for the boards.
